← Leaderboards
Abraham P Lee
University Of California-Irvine
$2,915,919
Attributed
$4,456,087
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $800.1K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,456,087 · 7
By mechanism
R01$1,833,971 · 2
R33$1,102,954 · 1
R21$784,209 · 2
R43$600,000 · 1
R03$134,953 · 1
Top collaborators
- Anshu Agrawal4 shared
- Rashid Bashir2 shared
- Steven Carl George2 shared
- Christopher C. W. Hughes2 shared
- Xiaowu Liang2 shared
- Marian L Waterman2 shared
Most similar at University Of California-Irvine
Same institution · by research overlap
- Anshu Agrawal$3,499,313
Others in their field
Top investigators on “Microfluidics”
- Richard A Gibbs · Baylor College Of Medicine$91,745,423
- Roger T Howe · University Of California-Berkeley$89,901,072
- Daniel C Ralph · Cornell University$89,901,072
- Mehmet Toner · Massachusetts General Hospital$43,728,700
- Vamsee K Pamula · Advanced Liquid Logic$32,521,508
- Robert B Darnell · Rockefeller University$24,511,943
Research focus
MicrofluidicsCellsComplexProteinsMembraneMalignant NeoplasmsT-LymphocyteEngineeringMechanicsCell MembraneBaseMolecularCancer ImmunotherapyProductionMicrofluidic MicrochipsAcousticsPrototypeIn VivoDesign3-DimensionalCostInnovationIn VitroAntigens
Grant awards (18)
Acoustic microvortices instrumentation for dosage controlled, high efficiency cell engineering$303,678
R01 · FY2025 · GM · contact PI
Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy$156,730
R33 · FY2025 · CA · contact PI
Acoustic microvortices instrumentation for dosage controlled, high efficiency cell engineering$295,827
R01 · FY2024 · GM · contact PI
Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy$205,000
R33 · FY2024 · CA · contact PI
Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy$373,718
R33 · FY2023 · CA · contact PI
Acoustic microvortices instrumentation for dosage controlled, high efficiency cell engineering$296,930
R01 · FY2023 · GM · contact PI
Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy$367,506
R33 · FY2022 · CA · contact PI
Acoustic microvortices instrumentation for dosage controlled, high efficiency cell engineering$280,482
R01 · FY2022 · GM · contact PI
Microfluidic Engineering of Artificial-Antigen Presenting Cells for the Biomanufacturing of Tumor-Specific T-Cells$216,028
R21 · FY2019 · EB · contact PI
Microfluidic Engineering of Artificial-Antigen Presenting Cells for the Biomanufacturing of Tumor-Specific T-Cells$176,380
R21 · FY2018 · EB · contact PI
"LLISA:'Liposome-Linked Immunosorbant Assay' for Detection of HIV Viral Load at Point-of-Care"$210,580
R21 · FY2014 · AI
A 3-D in vitro platform of tumor metastasis (PQ24)$318,879
R01 · FY2013 · CA
Integrated Microfluidic Platform for Point-of-Care Serodiagnostics$300,000
R43 · FY2013 · AI
LLISA: ???Liposome-Linked Immunosorbant Assay??? for Detection of HIV Viral Load$181,221
R21 · FY2013 · AI
A 3-D in vitro platform of tumor metastasis (PQ24)$338,175
R01 · FY2012 · CA
Integrated Microfluidic Platform for Point-of-Care Serodiagnostics$300,000
R43 · FY2012 · AI
Microfluidics systems for formulation of contrast agents for molecular imaging$67,887
R03 · FY2008 · EB · contact PI
Microfluidics systems for formulation of contrast agents for molecular imaging$67,066
R03 · FY2007 · EB · contact PI